March 04, 2015 8:09 AM ET

Healthcare Equipment and Supplies

Company Overview of Dune Medical Devices Corporation

Executive Profile

Daniel J. Levangie B.S.

President of Insulet Drug Delivery, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 11 different industries.

See Board Relationships
63$252,729

Background

Mr. Daniel J. Levangie, also known as Dan, has been President of Insulet Drug Delivery at Insulet Corporation since February 10, 2015. Mr. Levangie was a Managing Partner and Principal at Constitution Medical Investors. He has over three decades of industry experience including leadership expertise in the commercial operations and sales and marketing of medical devices and pharmaceuticals. Mr. Levangie served as a Managing Partner of ATON Partners, LLC, Investment Arm ...

Corporate Headquarters

20 Alon Hatavor Street
Caesarea, -- 38900

Israel

Phone: 972 4 617 8000
Fax: 972 4 627 0642

Board Members Memberships

Chief Executive Officer and Director
Chairman
Chairman
2003-N/A
Former Chief Commercial Officer, Executive Vice President, Director and President of Cytyc Surgical Products Division
2007-2008
Former Director
2007-Present
Non-Executive Chairman and Member of Nominating, Corporate Governance & Compliance Committee
2010-Present
Independent Director, Member of Corporate Governance & Nominating Committee and Member of Innovation & Technology Committee
2010-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2011-2015
President of Insulet Drug Delivery

Education

BS
Northeastern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$61,371
Total Calculated Compensation$252,729
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$985.0K
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
$325.0K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
$1.5M
Yasuchika Hasegawa Chairman and Chief Executive Officer
Takeda Pharmaceutical Company Limited
$216.0M
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$472.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Dune Medical Devices Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.